Description: Most of us clinicians are familiar with the concept of dysbiosis. While this term has been a mainstay of functional GI evaluations for a long time, is it due for an update? Dysbiosis can have several different meanings and still lacks clear diagnostic specificity. Given that the
literature into the microbiome seems to be ever-evolving, what can be done to align our new insights with our clinical tools?

In this webinar, Dr Jeffrey Bland, Dr. Tom Guilliams, and Dr. Michael Chapman will dive into some of the unique things we have learned that might impact how we view “dysbiosis.” What are some of the important pattern shifts? What new interventions exist in the probiotic realm? What is the main goal of microbiome modulation? Join us to explore these topics and more!